New heterocyclic scaffolds for drug discovery

被引:0
|
作者
Winograd, Lexie [1 ]
Wang, Yufei [1 ]
Stevens, Erland P. [1 ]
机构
[1] Davidson Coll, Dept Chem, Davidson, NC 28035 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
214-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [2] Privileged heterocyclic scaffolds in chemical biology and drug discovery: synthesis and bioactivity
    Altomare, Cosimo Damiano
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2017, 53 (03) : 239 - 239
  • [3] A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery
    Kalaria, Piyush N.
    Karad, Sharad C.
    Raval, Dipak K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 158 : 917 - 936
  • [4] PHYTOCHEMICALS AS SCAFFOLDS FOR NEW DRUG SYNTHESIS AND DISCOVERY
    Sporn, Michael B.
    PHARMACEUTICAL BIOLOGY, 2012, 50 (05) : 611 - 611
  • [5] Polycyclic Sulfoximines as New Scaffolds for Drug Discovery
    Borst, Mark L. G.
    Ouairy, Cecile M. J.
    Fokkema, Sander C.
    Cecchi, Alessandro
    Kerckhoffs, Jessica M. C. A.
    de Boer, Vincent L.
    van den Boogaard, Peter J.
    Bus, Rutger F.
    Ebens, Rijko
    van der Hulst, Rob
    Knol, Joop
    Libbers, Rob
    Lion, Zhou M.
    Settels, Bart W.
    de Weyer, Ellen
    Attia, Khaled A.
    Sinnema, Piet-Jan
    de Gooijer, Jesse M.
    Harkema, Karen
    Hazewinkel, Marieke
    Snijder, Susan
    Pouwer, Kees
    ACS COMBINATORIAL SCIENCE, 2018, 20 (06) : 335 - 343
  • [6] Indoloquinolines as Scaffolds for Drug Discovery
    Lavrado, J.
    Moreira, R.
    Paulo, A.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (22) : 2348 - 2370
  • [7] Spirocyclic scaffolds in drug discovery
    Tice, Colin
    Zheng, Yajun
    Singh, Suresh
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [8] Carbohydrates as scaffolds in drug discovery
    Meutermans, Wirn
    Le, Giang Thanh
    Becker, Bernd
    CHEMMEDCHEM, 2006, 1 (11) : 1164 - 1194
  • [10] Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
    Ali, Imran
    Lone, Mohammad Nadeem
    Al-Othman, Zeid A.
    Al-Warthan, Abdulrahman
    Sanagi, Mohd Marsin
    CURRENT DRUG TARGETS, 2015, 16 (07) : 711 - 734